You spotted FRABOC in an old medical record and now worry about what it means. The original tool no longer exists through Cancer Australia, so online searches hit dead ends and leave you anxious. This guide explains exactly what the assessment covered, what each risk category meant, and which modern tools now deliver accurate breast and ovarian cancer risk evaluation.
What Is FRABOC and Why Does It Appear in Medical Records?
FRABOC stood for Familial Risk Assessment – Breast and Ovarian Cancer. Australian health professionals used this tool to evaluate breast and ovarian cancer patterns within families.
The system reviewed which relatives had cancer, what type they developed, and their age at diagnosis. GPs and nurses primarily used FRABOC during consultations to determine whether a patient’s family history warranted further investigation.
You might encounter this name in old referral letters, PDF health summaries, or archived clinical notes. Its presence simply means a clinician reviewed your family cancer history at that time.
Table of Contents
How Did FRABOC Assess Breast and Ovarian Cancer Risk?
The tool gathered family history information from both the maternal and paternal sides. A health professional asked about first-degree relatives (parents, siblings, children) and second-degree relatives (grandparents, aunts, uncles, nieces, nephews).
FRABOC then sorted patients into broad risk groups based on the patterns it identified. The result was an estimate, not a prediction. It reflected the information available at that specific point in time.
Incomplete family knowledge sometimes limited accuracy. Many people do not know the exact cancer types or diagnosis ages of distant relatives, which is why a trained clinician guided the process.
Which Family History Factors Did FRABOC Consider?
The assessment went beyond simply counting relatives with cancer. Specific patterns carried more weight in the evaluation.
Key factors the tool evaluated:
- Breast cancer diagnosed before age 50
- Male breast cancer at any age
- Cancer affecting both breasts in one person
- Both breast and ovarian cancer in the same family
- Multiple close relatives with breast or ovarian cancer
- Known inherited gene changes such as BRCA1 or BRCA2 variants
Both sides of the family mattered equally. Cancer-related gene changes pass through either parent, so ignoring the father’s family history could miss critical risk signals.
What Do the Three FRABOC Risk Categories Actually Mean?
FRABOC sorted people into three broad groups. Understanding each category helps clarify old medical records.
At or Slightly Above Average Risk: Family history showed no strong signs of inherited cancer risk. This did not guarantee cancer would never develop. It meant the family pattern resembled that of the general population.
Moderately Increased Risk: The family history contained notable patterns, such as a close relative diagnosed with breast cancer at a younger age or more than one affected relative. Additional monitoring or assessment might have been recommended.
Potentially High Risk: The family history included several cases of breast or ovarian cancer, very early diagnoses, male breast cancer, or a known inherited gene change. Referral to a family cancer service or genetic counselling was typically the next step.
These categories are now outdated. They should not guide current health decisions.
Was FRABOC a Cancer Test or Genetic Screening?
No. FRABOC was not a mammogram, ultrasound, biopsy, blood test, or genetic analysis. It could not detect whether someone currently had breast or ovarian cancer.
The tool also did not examine DNA. BRCA1 and BRCA2 genetic testing involves analyzing a person’s actual gene sequences for harmful variants. The FRABOC system performed no such analysis.
It assessed risk based on family patterns alone. A high-risk result meant further evaluation might help — not that cancer was present or inevitable.
What Happened After a Higher FRABOC Risk Result?
A higher risk result triggered further clinical conversation, not automatic treatment. Health professionals used the information to decide on appropriate next steps.
Common follow-up actions included:
- Detailed family history review with a specialist
- Referral to a family cancer clinic
- Discussion about genetic counselling
- Consideration of genetic testing as a separate process
- Adjusted breast cancer screening schedules
Each person’s situation guided the plan. The assessment served as one piece of a broader clinical picture, not a standalone directive.
Is FRABOC Still Available Through Cancer Australia?
No. Cancer Australia retired the original FRABOC tool. The name persists in old medical records, archived web pages, and outdated referral forms — which explains why many people search for it today and find nothing current.
An old FRABOC result may help explain past clinical decisions. It should not determine your current cancer risk. Medical guidelines, risk models, and screening recommendations have all advanced significantly since the tool was active.
What Replaced FRABOC for Breast Cancer Risk Assessment?
Modern tools now provide more detailed and personalized risk estimates. The three most prominent options available in Australia include iPrevent, CanRisk, and IBIS (Tyrer-Cuzick model).
These systems go beyond family history alone. They incorporate personal medical data, reproductive history, lifestyle factors, and breast density information when available. This broader data input produces more accurate individual risk profiles than the older FRABOC categories ever could.
Your GP or specialist can determine which tool best suits your situation.
How Does iPrevent Compare to the Old FRABOC System?
iPrevent is an Australian breast cancer risk assessment tool developed in connection with the Peter MacCallum Cancer Centre. It represents a significant step forward from the FRABOC approach.
Key differences between iPrevent and FRABOC:
- iPrevent combines family history with personal health, reproductive, and lifestyle data
- FRABOC relied primarily on family cancer patterns
- iPrevent generates individualized risk estimates rather than broad group categories
- iPrevent supports shared decision-making about screening and risk management
- FRABOC is retired; iPrevent is actively maintained and updated
Neither tool diagnoses cancer. Both estimate risk to guide clinical conversations.
What Are CanRisk and IBIS in Cancer Risk Assessment?
CanRisk is an online tool built on the BOADICEA model family. It integrates detailed family history, genetic test results, and polygenic risk scores to calculate breast and ovarian cancer probabilities. Health professionals and genetic counsellors frequently use CanRisk for patients with complex family histories.
IBIS, also known as the Tyrer-Cuzick model, combines family history with personal risk factors including hormonal history, breast density, and body mass index. It provides both short-term and lifetime breast cancer risk estimates.
Both tools complement iPrevent and offer different strengths depending on the clinical scenario.
Why Does Family Cancer History Still Matter Today?
FRABOC may be retired, but family cancer history remains one of the most valuable pieces of information you can share with your doctor. Collecting accurate details helps clinicians choose the right screening and prevention strategies.
Information worth gathering before your appointment:
- Which relatives had cancer and their relationship to you
- Cancer type and age at diagnosis for each affected relative
- Whether any relative had cancer in both breasts
- Whether any male relative developed breast cancer
- Whether anyone in the family underwent genetic testing
- Whether a specific inherited gene change was identified
Include both maternal and paternal sides. If you lack certain details, tell your doctor honestly rather than guessing.
What Should You Do If FRABOC Appears in Your Old Records?
Finding FRABOC in an old document does not mean you had cancer or carry a dangerous gene change. It means a clinician reviewed your family history at that time and assigned a risk category based on the information available then.
Your situation has likely changed since that assessment. You are older, new cancer cases may have emerged in your family, and genetic testing options have expanded considerably.
Schedule an appointment with your GP to review your current family history. They can use modern tools like iPrevent or CanRisk to provide an up-to-date risk evaluation that reflects today’s medical knowledge.
FRABOC vs. Modern Cancer Risk Tools: Detailed Comparison
| Feature | FRABOC | iPrevent | CanRisk (BOADICEA) | IBIS (Tyrer-Cuzick) |
| Current Status | Retired | Active | Active | Active |
| Primary Purpose | Family history grouping | Personalized breast cancer risk | Detailed genetic risk modeling | Combined risk estimation |
| Cancer Types Covered | Breast and ovarian | Breast | Breast and ovarian | Breast |
| Family History Input | Yes | Yes | Yes (detailed) | Yes |
| Genetic Test Integration | No | Limited | Yes (BRCA1/2, PALB2, others) | Limited |
| Personal Risk Factors | No | Yes (lifestyle, reproductive) | Partial | Yes (hormonal, BMI, density) |
| Risk Output Format | Three broad groups | Individualized estimate | Probability percentages | 10-year and lifetime risk |
| Intended Users | GPs and nurses | Clinicians and patients | Genetic specialists | Clinicians |
| Country of Origin | Australia | Australia | United Kingdom | United Kingdom |
| Breast Density Considered | No | Yes | Yes | Yes |
| Polygenic Risk Scores | No | No | Yes | No |
| Free to Access | Was (now retired) | Yes | Yes | Varies by provider |
.Take Control of Your Cancer Risk Knowledge Today
Understanding your family cancer history empowers you to make informed health decisions. FRABOC served an important role in Australian healthcare by helping clinicians identify families who might benefit from closer monitoring and genetic evaluation.
That role now belongs to more advanced tools. iPrevent, CanRisk, and IBIS deliver personalized risk estimates that reflect your complete health picture — not just broad family patterns.
Your next steps are straightforward:
- Gather family cancer history details from both sides of your family.
- Schedule a conversation with your GP about your current risk profile.
- Ask whether iPrevent or another modern tool is appropriate for your situation.
- Follow through on any recommended screening or genetic counselling referrals.
Knowledge reduces uncertainty. Act on it now rather than waiting for your next routine check-up